| Biological Sciences | Lifetime | 100 | US 59 | 99.99 |
| Medical and Health Sciences | Lifetime | 521 | US 282 | 99.98 |
| Genetics | Lifetime | 10 | US 3 | 99.96 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 43 | US 24 | 99.86 |
| Pharmacology | Lifetime | 19 | US 14 | 99.81 |
| Molecular Biology | Lifetime | 280 | US 187 | 99.87 |
| Surgery | Lifetime | 506 | US 281 | 99.55 |
| Oncology | Lifetime | 491 | US 275 | 99.10 |
| Cancer Research | Lifetime | 270 | US 146 | 98.42 |
| Health, Toxicology and Mutagenesis | Lifetime | 589 | US 219 | 97.37 |
| Biochemistry | Lifetime | 511 | US 237 | 92.42 |
| Clinical Biochemistry | Lifetime | 494 | US 221 | 90.63 |
| Reproductive Medicine | Lifetime | 871 | US 416 | 87.93 |
| Behavioral Neuroscience | Lifetime | 371 | US 225 | 88.04 |
| Genetics | 2021-2025 | 464 | US 172 | 87.39 |
| Hormonal Regulation and Hypertension | Lifetime | 4 | US 3 | 99.90 |
| Estrogen and related hormone effects | Lifetime | 6 | US 5 | 99.97 |
| Steroid Chemistry and Biochemistry | Lifetime | 1 | US 1 | 99.93 |
| Hormonal and reproductive studies | Lifetime | 7 | US 5 | 99.86 |
| Pharmacogenetics and Drug Metabolism | Lifetime | 5 | US 3 | 99.82 |
| Cholesterol and Lipid Metabolism | Lifetime | 9 | US 7 | 99.78 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 20 | US 12 | 99.79 |
| Retinoids in leukemia and cellular processes | Lifetime | 11 | US 9 | 99.80 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 18 | US 14 | 99.69 |
| Drug Transport and Resistance Mechanisms | Lifetime | 43 | US 20 | 99.67 |
| Reproductive System and Pregnancy | Lifetime | 64 | US 31 | 99.39 |
| Inflammatory mediators and NSAID effects | Lifetime | 61 | US 35 | 99.35 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 97 | US 47 | 99.21 |
| Nuclear Receptors and Signaling | Lifetime | 35 | US 21 | 99.41 |
| Cancer, Lipids, and Metabolism | Lifetime | 172 | US 95 | 99.19 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 137 | US 70 | 98.88 |
| Diet and metabolism studies | Lifetime | 687 | US 303 | 98.80 |
| Menopause: Health Impacts and Treatments | Lifetime | 57 | US 44 | 98.40 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 242 | US 125 | 98.52 |
| Metabolism and Genetic Disorders | Lifetime | 573 | US 241 | 98.17 |
| Phytoestrogen effects and research | Lifetime | 109 | US 60 | 97.99 |
| NF-κB Signaling Pathways | Lifetime | 188 | US 84 | 97.96 |
| HER2/EGFR in Cancer Research | Lifetime | 346 | US 161 | 98.50 |
| Pharmacological Effects and Assays | Lifetime | 146 | US 55 | 97.65 |
| Effects and risks of endocrine disrupting chemicals | Lifetime | 283 | US 88 | 98.34 |
| Prostate Cancer Treatment and Research | Lifetime | 510 | US 277 | 98.56 |
| Chemical Reactions and Isotopes | Lifetime | 186 | US 108 | 97.61 |
| Stress Responses and Cortisol | Lifetime | 498 | US 275 | 98.18 |
| Adipose Tissue and Metabolism | Lifetime | 965 | US 417 | 97.83 |
| Receptor Mechanisms and Signaling | Lifetime | 878 | US 437 | 98.09 |
| Toxic Organic Pollutants Impact | Lifetime | 610 | US 170 | 97.60 |
| Heat shock proteins research | Lifetime | 336 | US 149 | 96.27 |
| Sexual Differentiation and Disorders | Lifetime | 400 | US 168 | 96.90 |
| Hypothalamic control of reproductive hormones | Lifetime | 341 | US 185 | 96.32 |
| Glutathione Transferases and Polymorphisms | Lifetime | 318 | US 135 | 95.22 |
| Lipid metabolism and biosynthesis | Lifetime | 532 | US 230 | 95.69 |
| Fatty Acid Research and Health | Lifetime | 954 | US 350 | 94.69 |
| Adrenal Hormones and Disorders | Lifetime | 801 | US 295 | 93.02 |
| Redox biology and oxidative stress | Lifetime | 499 | US 185 | 91.49 |
| 14-3-3 protein interactions | Lifetime | 626 | US 248 | 82.05 |
| Estrogen and related hormone effects | 2021-2025 | 66 | US 31 | 94.58 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 75 | US 17 | 87.75 |
